Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics, safety, and efficacy of dolutegravir dispersible tablet in young children living with HIV
TCTR20201025001Phase 2Not yet recruiting
- Sponsor
- Faculty of Medicine, Chulalongkorn University
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dolutegravir in human immunodeficiency virus infection (HIV), sponsored by Faculty of Medicine, Chulalongkorn University. Planned start Jan 2021; status: not yet recruiting.
02
Drugs
dolutegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on TCTR20201025001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20201025001.